Dr. Crane is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4420 Lake Boone Trl
Ste 200
Raleigh, NC 27607Phone+1 919-784-6818Fax+1 919-784-6826
Summary
- Retired
Education & Training
National Capital ConsortiumFellowship, Hematology and Medical Oncology, 1981 - 1984- National Capital ConsortiumResidency, Internal Medicine, 1979 - 1981
- National Capital ConsortiumInternship, Internal Medicine, 1977 - 1978
University of Florida College of MedicineClass of 1977
University of Florida; Undergraduate StudiesBS, Zoology, Graduated with Honors, 1969 - 1973
Certifications & Licensure
NC State Medical License 2021 - 2025
MD State Medical License 1977 - 1990
SC State Medical License 1984 - 1987- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Lifetime Achievement Award: 2017 UNC Rex Medical Staff, 2017
- Top Physician 2005-2015
- NC Hospice and Home Health Leadership Excellence Award 2015
- Join now to see all
Clinical Trials
- Single Arm on the Tolerability of Weekly Nab-paclitaxel Start of enrollment: 2013 Jun 25
- Improving Survivorship Care Through Enhanced Communication and Coordination: Pilot Study Start of enrollment: 2013 Dec 01
Publications & Presentations
PubMed
- 140 citationsNeoadjuvant Clinical Trial With Sorafenib for Patients With Stage II or Higher Renal Cell CarcinomaC. Lance Cowey, Chirag Amin, Raj S. Pruthi, Eric Wallen, Matthew E. Nielsen
Journal of Clinical Oncology. 2010-03-20 - 12 citationsNab-paclitaxel in older patients with non–small cell lung cancer who have developed disease progression after platinum-based doublet chemotherapyJared Weiss, Nathan A. Pennell, Allison M. Deal, Daniel Morgensztern, Daniel S. Bradford
Cancer. 2020-03-01 - 64 citationsA phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancerYoung E. Whang, Andrew J. Armstrong, W. Kimryn Rathmell, Paul A. Godley, William Y. Kim
Urologic Oncology. 2013-01-01
Committees
- Hematology MED Oncology representative, BC/BS of NC Professional and Technical Review Board 1999 - 2015
- Am Soc of Clin Oncol representative, AMA; Medical Accreditation and Quality Improvement 1998 - 2002
- Chairman, Executive Committee of Rex Healthcare 1998 - 1999
- Hematology, Medical Oncology Representative, State of NC Medicare Advisory Panel 1997 - 2001
- President, RexHealthcare Medical Staff 1997 - 1998
- Chairman, Rex Department of Internal Medicine 1995 - 1997
- President, North Carolina Oncology Society 1994 - 1996
- State of NC representative, Am Soc of Clin Oncol; Clinical Practice Committee 1992 - 2004
- Secretary and Treasurer, Rex Healthcare Executive Committee 1991 - 1993
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
